Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
217–252
Headlines
734
Sources here
3
Companies here
24
Current section Germany Healthcare news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

1 Profitable Stock with Impressive Fundamentals and 2 We Turn Down

1 Profitable Stock with Impressive Fundamentals and 2 We Turn Down While profitability is essential, it doesn't guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, "Your margin is my opportunity". Not …

CVS mentioned
Sharemaestro market context Trend signal active 52 weeks +45.4% CVS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call

5 Insightful Analyst Questions From Vertex Pharmaceuticals's Q2 Earnings Call Vertex Pharmaceuticals' second quarter reflected strong commercial momentum, with management highlighting the performance of its cystic fibrosis (CF) portfolio and accelerating uptake of newer products like CASGEVY and JOURNAVX. CEO Reshma Kewalramani attributed revenue …

VX1 main company
Sharemaestro market context Trend signal active 52 weeks +27.0% VX1 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

technotrans SE (WBO:TTR1) (Q2 2026) Earnings Call Highlights: Margin Resilience and Strategic ...

This article first appeared on GuruFocus. Revenue: EUR113.3 million in H1 2026, down 6% from EUR120.6 million in the prior year. EBIT: EUR8.0 million in H1 2026, compared to EUR8.4 million one year ago. EBIT Margin: Increased to 7.1% from 7.0% in the prior …

BAYN mentioned
Sharemaestro market context Trend signal active 52 weeks +84.7% BAYN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Align Technology Prevails in China Patent Infringement Action Against Angelalign

SAN JOSE, Calif. & TEMPE, Ariz., August 12, 2026--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a …

AFW main company
Sharemaestro market context Trend signal active 50 weeks -52.5% · Next-week setup negative 40.0% AFW stored weekly price path from 8 Aug 2025 to 7 Aug 2026

Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?

Thermo Fisher Scientific (NYSE:TMO) mostly sells the instruments and supplies that let other companies do science, not the treatments themselves. So when the company said on July 29 that it had launched the PPD CorEvitas Vitiligo Registry on July 14, to track how patients …

TN8 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +21.8% TN8 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

SBO Strengthens Position in 3D Metal Printing: Expanded Capacity in the US and the UK, Award for 3T

TERNITZ, AUSTRIA - August 11, 2026 (NEWMEDIAWIRE) - SBO AG, listed on the leading index ATX of the Vienna Stock Exchange, is expanding its 3D metal printing capacity in the US and the UK and strengthening its market position in Europe through an award …

NOT mentioned
Sharemaestro market context Trend signal active 52 weeks +32.0% · Next-week setup positive 64.7% NOT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Earnings To Watch: Cardinal Health (CAH) Reports Q2 Results Tomorrow

Earnings To Watch: Cardinal Health (CAH) Reports Q2 Results Tomorrow Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday before market hours. Here's what to expect. Cardinal Health missed analysts' revenue expectations last quarter, reporting revenues of $60.94 …

CVS mentioned
Sharemaestro market context Trend signal active 52 weeks +45.4% CVS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program

MacroGenics, Inc. ROCKVILLE, MD, Aug. 11, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Gilead Sciences, Inc. has exercised its option to obtain an exclusive license …

GIS mentioned
Sharemaestro market context Price below Trend Line 52 weeks +18.2% · Next-week setup positive 57.6% GIS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results

Absci Corporation Announced positive interim Phase 1 data from the HEADLINE™ trial of ABS-201 Completed $100 million underwritten offering, including $40 million strategic investment from Eli Lilly & Company Cash, cash equivalents, and marketable securities now sufficient to fund operations into the second half …

LLY mentioned
Sharemaestro market context Trend signal active 52 weeks +73.4% · Next-week setup positive 55.4% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn’t Buy This Merger Talk

AstraZeneca PLC (NYSE:AZN) shares closed down as much as 9% on Monday, the stock's biggest one-day drop since 2020, after reports that it held merger talks with U.S. rival Bristol-Myers Squibb Company (NYSE:BMY). A combined company would be worth close to $400 billion, the …

BRM mentioned
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 57.3% BRM stored weekly price path from 15 Aug 2025 to 7 Aug 2026

This Buffett Oil Stock Is Quietly Outperforming Chevron Under Greg Abel. Is It Worth Buying Now?

Key Points Occidental shares have soared by nearly 36% since Greg Abel became Berkshire Hathaway's CEO in January. Further gains hinge highly on a resurgence in crude oil prices, making Oxy a more binary bet than Chevron, another top Berkshire Hathaway oil stock holding. …

UNH mentioned
Sharemaestro market context Trend signal active 52 weeks +38.7% UNH stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Talen Energy (TLN) Raised Guidance In August, So Why The Loss?

On August 5, Talen Energy (NASDAQ:TLN) posted a net loss for the second quarter, and yet the same release raised the company's full-year 2026 outlook and lifted its expectations for 2027 and 2028. That looks like a contradiction until you separate the accounting from …

TN8 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +21.8% TN8 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Eli Lilly Scores Major Win in Weight-Loss Drug Race

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) has secured U.K. approval for its once-daily weight-loss pill Foundayo, giving the drugmaker its first regulatory win for the treatment outside the U.S. and escalating its obesity battle with Novo Nordisk. The approval expands Lilly's …

LLY main company NOV mentioned
Sharemaestro market context Trend signal active 52 weeks +73.4% · Next-week setup positive 55.4% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Jim Cramer Highlights Arista Networks (ANET) Following Q2 Beat and 50% Rally

Arista Networks, Inc. (NYSE:ANET) posted $3.04 billion in total sales for Q2 2026, which represents a 37.7% year-over-year increase and beat Wall Street consensus estimates by $210 million. Non-GAAP earnings per share came in at $1.02, topping expectations by $0.13. The top-line expansion pulled …

JNJ mentioned
Sharemaestro market context Trend signal active 52 weeks +52.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Genmab A/S Company Announcement COPENHAGEN, Denmark; August 11, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 24,592 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of …

GE9 main company
Sharemaestro market context Price above Trend Line 41 weeks -18.6% GE9 stored weekly price path from 31 Oct 2025 to 7 Aug 2026

Arrow Exploration confirms four zones at Icaco 3, opens up ~10 new drilling locations

Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) CEO Marshall Abbott tells Proactive's Stephen Gunnion that the Icaco 3 well has confirmed up to four hydrocarbon-bearing zones in the Icaco extension of the Tapir Block in Colombia, opening almost 10 additional development locations across the Ubaque, …

ABL mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

2 Stocks I Think Are Hands-Down Better Picks Than SpaceX Right Now

Space Exploration Technologies (NASDAQ: SPCX) has been perhaps the most talked-about stock on Wall Street since it completed the largest IPO ever in mid-June. Opinions on the company's prospects are divided. Some see an innovative company that has already disrupted the space travel industry …

LLY mentioned
Sharemaestro market context Trend signal active 52 weeks +73.4% · Next-week setup positive 55.4% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

How Much Did Immunology Drugs Contribute to AbbVie's Q2 Performance?

AbbVie ABBV announced encouraging second-quarter 2026 results last month, which beat expectations for both earnings and sales. A significant portion of this growth came from the continued strength of its two blockbuster immunology medications, Skyrizi and Rinvoq, which together accounted for more than 47% …

LLY mentioned JNJ mentioned
Sharemaestro market context Trend signal active 52 weeks +73.4% · Next-week setup positive 55.4% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Jim Cramer Weighs In on Sentiment Shifts Driving Accenture and Cognizant Rallies

On Monday's CNBC Mad Money episode, host Jim Cramer examined the top-performing stocks in the S&P 500, focusing on the dramatic turnaround in IT consulting leaders Cognizant Technology Solutions Corporation (NASDAQ:CTSH) and Accenture plc (NYSE:ACN). Addressing how market sentiment shifted around the "AI displacement …

JNJ mentioned
Sharemaestro market context Trend signal active 52 weeks +52.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

Quick Read LEGN surged 6% as Q2 revenue of $388M beat estimates and adjusted EPS of $0.16 doubled consensus, marking the company's first-ever profitable quarter. CARVYKTI net sales hit $657M, up 50%, with JNJ co-developer Janssen supporting management's target of over $5B in peak …

JNJ mentioned BRM mentioned
Sharemaestro market context Trend signal active 52 weeks +52.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026

BridgeBio Q2 Earnings Miss, Revenues Beat as Attruby Sales Surge

BridgeBio Pharma BBIO reported a second-quarter 2026 loss of 78 cents per share, wider than the Zacks Consensus Estimate of a loss of 64 cents. Despite the miss, the figure improved compared to the year-ago loss of 95 cents. Revenues surged 120% year over …

PFE mentioned
Sharemaestro market context Price above Trend Line 52 weeks +13.2% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026

IDEXX (IDXX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Mike Erickson Chief Financial Officer - Andrew Emerson Vice President, Investor Relations - John Ravis Full Conference Call Transcript Operator: Good morning, …

IX1 main company
Sharemaestro market context Price below Trend Line 50 weeks +29.7% · Next-week setup negative 28.4% IX1 stored weekly price path from 8 Aug 2025 to 7 Aug 2026

Should Investors Buy Inogen as Low Valuation Meets Execution Risk?

Inogen, Inc. INGN trades at a steep sales-multiple discount even as second-quarter 2026 margins improved and international demand remained firm. The disconnect creates an interesting setup, but the operating recovery is not yet broad-based. Investors must weigh better cost control, expanding respiratory offerings and …

PHI1 mentioned
Sharemaestro market context Price below Trend Line 52 weeks +2.8% · Next-week setup positive 56.0% PHI1 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Roche (SWX:ROG) Stock Fair Value Edges Higher As Analysts Weigh Pipeline Growth

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Roche Holding now sits on a refreshed fair value estimate of CHF 370.31, up from CHF 359.22. This gives you an updated reference point for where analysts …

RHO mentioned
Sharemaestro market context Price above Trend Line 52 weeks +44.8% · Next-week setup positive 61.8% RHO stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Pfizer (PFE) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 11:00 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Albert Bourla Chief Financial Officer - David Denton Incoming Interim Chief Financial Officer and Executive Vice President - Cecile Guegan Chief Scientific …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +13.2% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

European equities traded in the US as American depositary receipts were tracking higher late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have …

NOV mentioned
Sharemaestro market context Trend signal active 52 weeks +23.9% · Next-week setup positive 59.0% NOV stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Lilly Takes Its Weight-Loss Pill Battle Overseas

This article first appeared on GuruFocus. Eli Lilly and Co. (LLY, Financials), the developer of Foundayo and Zepbound, has received U.K. approval for Foundayo, the first approval for the weight-loss medication outside of the U.S. The The strategy pits Lilly directly against Novo Nordisk's …

LLY main company NOV mentioned
Sharemaestro market context Trend signal active 52 weeks +73.4% · Next-week setup positive 55.4% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Tecan Group AG (TCHBF) (H1 2026) Earnings Call Highlights: Strategic Progress and Market ...

This article first appeared on GuruFocus. Release Date: August 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Tecan Group AG (TCHBF) delivered solid above-market growth in both segments, with group sales up …

NOT mentioned
Sharemaestro market context Trend signal active 52 weeks +32.0% · Next-week setup positive 64.7% NOT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026, at 9:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Chair of the Management Board - Helen Giza Chief Financial Officer - Martin Fischer Investor Relations - Dominik Heger Full Conference Call Transcript Operator: …

FME main company GME main company
Sharemaestro market context Trend signal active 52 weeks +2.6% FME stored weekly price path from 15 Aug 2025 to 7 Aug 2026

REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?

The going has been strong for Regeneron Pharmaceuticals REGN over the past month. Shares of this biotech giant have surged 21.9% over the said time frame, outpacing the industry's growth of 4%. The stock has also outperformed the sector and the S&P 500 Index …

RHO mentioned RGO mentioned BAYN mentioned
Sharemaestro market context Price above Trend Line 52 weeks +44.8% · Next-week setup positive 61.8% RHO stored weekly price path from 15 Aug 2025 to 7 Aug 2026

CVS Health Earns Two Gold and One Silver Stevie(R) Awards for Great Employers

AI Learning Academy honored for building enterprise-wide AI literacy and colleague confidence WOONSOCKET, RI / ACCESS Newswire / August 11, 2026 / Originally published on CVS Health Company Newsroom CVS Health® (NYSE:CVS) announced that its AI Learning Academy earned two Golds and one Silver …

CVS mentioned
Sharemaestro market context Trend signal active 52 weeks +45.4% CVS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year

The pharmaceutical sector differs from many industries as stock performance often depends less on near-term results and more on the success of products in development. For biotech companies, clinical and regulatory developments can sharply alter valuations by changing expectations for a drug's safety, efficacy …

VX1 mentioned
Sharemaestro market context Trend signal active 52 weeks +27.0% VX1 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

These stocks have some of Wall Street’s lowest short interest

[short sale] abluecup Stocks including Apple, Alphabet, Exxon Mobil, and JPMorgan are among the companies with relatively low short interest, according to a screen of stocks with market capitalizations above $2B. The screen includes stocks with short interest between 1% and 2% of shares …

LLY mentioned JNJ mentioned
Sharemaestro market context Trend signal active 52 weeks +73.4% · Next-week setup positive 55.4% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?

Quick Read BioCryst hit its first full year of profitability in 2025, with Q2 2026 revenue up 34% to $218 million, fueling acquisition speculation. Takeda (TAK) tops the buyer rankings as navenibart directly threatens its Takhzyro franchise; AstraZeneca (AZN) ranks second through its Alexion …

AMG mentioned SNW mentioned
Sharemaestro market context Trend signal active 52 weeks +44.5% AMG stored weekly price path from 15 Aug 2025 to 7 Aug 2026

J&J Trading Above 200- & 50-Day SMAs: Buy, Sell or Hold the Stock?

Johnson & Johnson JNJ stock has been trading above both its 50-day and 200-day simple moving averages (SMAs) since mid-June. Trading above the 200-day SMA indicates that the stock's longer-term trend has turned positive, while staying above the 50-day SMA suggests that shorter-term momentum …

LLY mentioned JNJ mentioned GIS mentioned
Sharemaestro market context Trend signal active 52 weeks +73.4% · Next-week setup positive 55.4% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run

Quick Read ISRG is down 31% YTD, but its razor-and-razorblade model now delivers 85% recurring revenue across a fleet of 11,710 da Vinci systems. MDT's Hugo and JNJ's Ottava remain early or pre-commercial, leaving ISRG's $1.73 billion quarterly instruments-and-accessories stream with no real soft-tissue …

JNJ mentioned IUI1 mentioned
Sharemaestro market context Trend signal active 52 weeks +52.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context